atxs: the income statement

MyFinsight

Astria Therapeutics, Inc. (ATXS)

For the quarter ending 2025-06-30, ATXS made $2,889K in revenue. -$33,052K in net income. Net profit margin of -1144.06%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

	2025-06-30
Research and development	25,945
General and administrative	9,875
Total operating expenses	35,820
Loss from operations	-35,820
Other expense, net	-121
Interest and investment income	2,889
Total other income, net	2,768
Net loss	-33,052

Earnings per share, basic	-0.57
Earnings per share, diluted	-0.57
Weighted average number of shares outstanding, basic	58,005,312
Weighted average number of shares outstanding, diluted	58,005,312

Unit: Thousand (K) dollars (except for numbers of shares and EPS)